Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

JNJ 95.16 -1.06 (-1.10%)
price chart
Johnson & Johnson facing massive class action
Medical giant Johnson & Johnson is facing its third class action in Australia in as many years, with a case filed in the Federal Court yesterday which relates to a product called transvaginal mesh.
Johnson & Johnson diabetes drug effective in high risk patients
An experimental treatment for type 2 diabetes developed by Johnson & Johnson proved effective at reducing blood sugar in patients on long-term insulin therapy and at high risk for heart problems, according to a study presented on Tuesday.
Johnson & Johnson Agrees to Settle Five Rispersal Suits
Oct. 4 (Bloomberg) -- Johnson & Johnson agreed to settle five lawsuits over claims that its antipsychotic drug Risperdal caused increased breast-tissue growth in boys.
J&J's Global Creative Review Nears Finish
Johnson & Johnson is close to concluding its global review of creative responsibilities for its over-the-counter brands and sources expect the bulk of the business to be consolidated at three roster shops: DDB, BBDO and JWT.
J&J Set to Consolidate Creative With Omnicom, WPP  AdAge.com
J.&J.'s Costs Take a Toll on Its Profit
Johnson & Johnson, the giant health care products maker, reported Tuesday that its third-quarter profit fell 7 percent as litigation and acquisition costs and factory upgrade expenses offset higher medicine and medical device sales.
Johnson & Johnson third-quarter profit hit by charges, currency fluctuations  The Star-Ledger - NJ.com
Johnson & Johnson Tops Forecasts on Lower Profit  Investorplace.com
Tylenol and the Legacy of J&J's James Burke
This post is in partnership with Knowledge@Wharton, the online research and business analysis journal of the Wharton School of the University of Pennsylvania.
Done with Creative Review, J&J Turns Sights to Global Media Review
Johnson & Johnson has concluded its global creative agency review and is preparing to launch a global media review in markets not already in review, including North America, company executives said today.
Johnson & Johnson
Senior forward Samantha Johnson recorded the fastest goal in the history of USC's women's soccer program, scoring just 14 seconds into a game last fall against Washington State.
Five reasons to like Johnson & Johnson
Johnson & Johnson has made headlines over the past couple of years - for all the wrong reasons. Plagued by quality control problems and costly product recalls affecting key brands such as Tylenol, Benadryl and Motrin, the health care giant's reputation ...
Lake Nona becomes 'living laboratory' for Johnson & Johnson
Residents, students and employees of Lake Nona are about to become the center of a long-term study that may reveal the secret to living a longer, healthier life, executives from Johnson & Johnson and Lake Nona Institute announced today.